Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BPI-452080
i
Other names:
BPI-452080, BPI452080, BPI 452080
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Betta Pharma
Drug class:
HIF-2α inhibitor
Related drugs:
‹
belzutifan (9)
DFF332 (0)
K-1299 (0)
NKT2152 (0)
SLM (0)
belzutifan (9)
DFF332 (0)
K-1299 (0)
NKT2152 (0)
SLM (0)
›
Associations
News
Trials
Filter by
Latest
over1year
A Study of BPI-452080 in Subjects With Solid Tumors (clinicaltrials.gov)
P1, N=87, Not yet recruiting, Betta Pharmaceuticals Co., Ltd.
over 1 year ago
New P1 trial
|
BPI-452080
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login